Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MAVRTX · Entity 2875 | VP, European Operations | May 06, 2004 | May 10, 2004 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
VERTEX PHARMACEUTICALS INC / MA
Report date May 06, 2004 · Filed May 10, 2004
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 22,094 |
Reported balance
After 2004-05-06 transaction · row 1
1 source rowRow 1 · 2004-05-06 · Grant · Acquired 20,000 · Balance 22,094 F1: Stock grant made under 1996 Stock and Option Plan, vesting 50% on May 6, 2009, subject to acceleration upon achievement of a performance-based milestone based on Company profitability, and 50% on May 6, 2007. |
Filing footnotes · ownership attribution and instrument terms
F1: Stock grant made under 1996 Stock and Option Plan, vesting 50% on May 6, 2009, subject to acceleration upon achievement of a performance-based milestone based on Company profitability, and 50% on May 6, 2007.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 06, 2004 Filed May 10, 2004 20:00 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantCommon Stock | 20,000 | $0.01 | $200.00 |
DisclosureSEC source: 0000875320-04-000049 · edgar.xml · nonDerivative · entry 1 BUCHANAN IAIN P M · CIK 0001197027 · VP, European Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,094 F1 · shares: Stock grant made under 1996 Stock and Option Plan, vesting 50% on May 6, 2009, subject to acceleration upon achievement of a performance-based milestone based on Company profitability, and 50% on May 6, 2007. Read SEC document |
| March 29, 2004 Filed Mar 30, 2004 21:07 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 10,000 | $0.00 Strike: $6.75 | $0.00 |
DisclosureSEC source: 0000875320-04-000027 · edgar.xml · derivative · entry 3 BUCHANAN IAIN P M · CIK 0001197027 · VP, European Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,139 Underlying: Common Stock · 10,000 shares Expires 2004-04-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1991 Stock and Option Plan, vesting in 20 equal quarterly installments from 4/5/1994. Read SEC document |
| March 29, 2004 Filed Mar 30, 2004 21:07 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 10,000 | $9.44 | $94,400.00 |
DisclosureSEC source: 0000875320-04-000027 · edgar.xml · nonDerivative · entry 2 BUCHANAN IAIN P M · CIK 0001197027 · VP, European Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,094 F1 · kind: Transaction made pursuant to Mr. Buchanan's approved trading plan established under Rule 10b 5-1. Read SEC document |
| March 29, 2004 Filed Mar 30, 2004 21:07 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 10,000 | $6.75 | $67,500.00 |
DisclosureSEC source: 0000875320-04-000027 · edgar.xml · nonDerivative · entry 1 BUCHANAN IAIN P M · CIK 0001197027 · VP, European Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,094 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 23, 2004 Filed Mar 24, 2004 20:17 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 7,500 | $0.00 Strike: $6.75 | $0.00 |
DisclosureSEC source: 0000875320-04-000024 · edgar.xml · derivative · entry 3 BUCHANAN IAIN P M · CIK 0001197027 · VP, European Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 309,139 Underlying: Common Stock · 7,500 shares Expires 2004-04-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1991 Stock and Option Plan, vesting in 20 equal quarterly installments from 4/5/1994. Read SEC document |
| March 23, 2004 Filed Mar 24, 2004 20:17 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 7,500 | $9.16 | $68,700.00 |
DisclosureSEC source: 0000875320-04-000024 · edgar.xml · nonDerivative · entry 2 BUCHANAN IAIN P M · CIK 0001197027 · VP, European Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,094 F1 · kind: Transaction made pursuant to Mr. Buchanan's approved trading plan established under Rule 10b 5-1. Read SEC document |
| March 23, 2004 Filed Mar 24, 2004 20:17 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 7,500 | $6.75 | $50,625.00 |
DisclosureSEC source: 0000875320-04-000024 · edgar.xml · nonDerivative · entry 1 BUCHANAN IAIN P M · CIK 0001197027 · VP, European Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,594 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 22, 2004 Filed Mar 23, 2004 16:41 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 2,500 | $0.00 Strike: $6.75 | $0.00 |
DisclosureSEC source: 0000875320-04-000023 · edgar.xml · derivative · entry 3 BUCHANAN IAIN P M · CIK 0001197027 · VP, European Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 316,639 Underlying: Common Stock · 2,500 shares Expires 2004-04-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1991 Stock and Option Plan, vesting in 20 equal quarterly installments from 4/5/1994. Read SEC document |
| March 22, 2004 Filed Mar 23, 2004 16:41 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 2,500 | $9.22 | $23,050.00 |
DisclosureSEC source: 0000875320-04-000023 · edgar.xml · nonDerivative · entry 2 BUCHANAN IAIN P M · CIK 0001197027 · VP, European Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,094 F1 · kind: Transaction made pursuant to Mr. Buchanan's approved trading plan established under Rule 10b 5-1. Read SEC document |
| March 22, 2004 Filed Mar 23, 2004 16:41 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 2,500 | $6.75 | $16,875.00 |
DisclosureSEC source: 0000875320-04-000023 · edgar.xml · nonDerivative · entry 1 BUCHANAN IAIN P M · CIK 0001197027 · VP, European Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,594 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 17:46 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 10,000 | $0.00 Strike: $6.75 | $0.00 |
DisclosureSEC source: 0000875320-04-000014 · edgar.xml · derivative · entry 3 BUCHANAN IAIN P M · CIK 0001197027 · VP, European Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 319,139 Underlying: Common Stock · 10,000 shares Expires 2004-04-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1991 Stock and Option Plan, vesting in 20 equal quarterly installments from 4/5/1994. Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 17:46 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 10,000 | $9.99 | $99,900.00 |
DisclosureSEC source: 0000875320-04-000014 · edgar.xml · nonDerivative · entry 2 BUCHANAN IAIN P M · CIK 0001197027 · VP, European Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,094 F1 · kind: Transaction made pursuant to Mr. Buchanan's approved trading plan established under Rule 10b 5-1. Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 17:46 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 10,000 | $6.75 | $67,500.00 |
DisclosureSEC source: 0000875320-04-000014 · edgar.xml · nonDerivative · entry 1 BUCHANAN IAIN P M · CIK 0001197027 · VP, European Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,094 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2004 Filed Mar 9, 2004 17:16 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 10,000 | $0.00 Strike: $6.75 | $0.00 |
DisclosureSEC source: 0000875320-04-000012 · edgar.xml · derivative · entry 3 BUCHANAN IAIN P M · CIK 0001197027 · VP, European Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 329,139 Underlying: Common Stock · 10,000 shares Expires 2004-04-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1991 Stock and Option Plan, vesting in 20 equal quarterly installments from 4/5/1994. Read SEC document |
| March 08, 2004 Filed Mar 9, 2004 17:16 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 10,000 | $11.15 | $111,500.00 |
DisclosureSEC source: 0000875320-04-000012 · edgar.xml · nonDerivative · entry 2 BUCHANAN IAIN P M · CIK 0001197027 · VP, European Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,094 F1 · kind: Transaction made pursuant to Mr. Buchanan's approved trading plan established under Rule 10b 5-1. Read SEC document |
| March 08, 2004 Filed Mar 9, 2004 17:16 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 10,000 | $6.75 | $67,500.00 |
DisclosureSEC source: 0000875320-04-000012 · edgar.xml · nonDerivative · entry 1 BUCHANAN IAIN P M · CIK 0001197027 · VP, European Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,094 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2004 Filed Mar 2, 2004 19:20 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 10,000 | $0.00 Strike: $6.75 | $0.00 |
DisclosureSEC source: 0000875320-04-000010 · edgar.xml · derivative · entry 3 BUCHANAN IAIN P M · CIK 0001197027 · VP, European Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 339,139 Underlying: Common Stock · 10,000 shares Expires 2004-04-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1991 Stock and Option Plan, vesting in 20 equal quarterly installments from 4/5/1994. Read SEC document |
| March 01, 2004 Filed Mar 2, 2004 19:20 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 10,000 | $11.28 | $112,800.00 |
DisclosureSEC source: 0000875320-04-000010 · edgar.xml · nonDerivative · entry 2 BUCHANAN IAIN P M · CIK 0001197027 · VP, European Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,094 F1 · kind: Transaction made pursuant to Mr. Buchanan's approved trading plan established under Rule 10b 5-1. Read SEC document |
| March 01, 2004 Filed Mar 2, 2004 19:20 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 10,000 | $6.75 | $67,500.00 |
DisclosureSEC source: 0000875320-04-000010 · edgar.xml · nonDerivative · entry 1 BUCHANAN IAIN P M · CIK 0001197027 · VP, European Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,094 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 11, 2003 Filed Dec 15, 2003 21:23 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantCommon Stock · Derivative | 8,184 | $0.00 Strike: $9.07 | $0.00 |
DisclosureSEC source: 0000875320-03-000059 · edgar.xml · derivative · entry 2 BUCHANAN IAIN P M · CIK 0001197027 · VP, European Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 349,139 Underlying: Commmon Stock · 8,184 shares Expires 2013-12-10 F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments from 12/11/2003. Read SEC document |
| December 11, 2003 Filed Dec 15, 2003 21:23 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantCommon Stock | 1,091 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-03-000059 · edgar.xml · nonDerivative · entry 1 BUCHANAN IAIN P M · CIK 0001197027 · VP, European Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,094 F1 · shares: Stock grant made under 1996 Stock and Option Plan, vesting in 4 equal annual installments from 12/11/2003. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.